Preclinical

Cannabis-based, non-cancer, chronic pain trial approved by NHS ethics committee

01-Aug-2023 By Liza Laws

The National Health Service (NHS) research ethics committee has approved a non-cancer chronic pain clinical trial being rolled out by private health clinic LVL Health.

AstraZeneca's Imfinzi has the potential to 'redefine care for patients with gastrointestinal cancers' interim analysis shows

08-Jun-2023 By Liza Laws

A new treatment approach to improve outcomes for patients with earlier stages of gastric and gastroesophageal junction cancers has had positive high-level results from a planned interim analysis of a phase 3 trial.

Clinical Trials Day 2023

Clinical trial diversity - a Q&A with Clincierge

01-Jun-2023 By Liza Laws

The US Food and Drug Administration will soon require researchers and companies seeking approval for late-stage clinical trials to submit a diversity plan for trial participants. Scott Gray, CEO of Clincierge, discusses how trial sponsors and CROs can...

Modern clinical trial needs of small and emerging biotech companies addressed by new partnership

25-May-2023 By Liza Laws

A partnership has been formed between Allucent, a biopharma services provider, has partnered with Thread, a decentralized clinical trial (DCT) and eCOA technology provider to launch Allucent Patient Direct Trials, a DCT focusing on small and mid-sized...

Breakthrough that could put an end to invasive surgery for rectal cancer patients

12-Apr-2023 By Liza Laws

A breakthrough in rectal cancer treatment has been discovered through a collaboration between a cancer intelligence company and the world’s largest and oldest cancer center. It could put an end to the invasive surgery patients may have faced.

Positive topline results in trial for patients with early breast cancer

28-Mar-2023 By Liza Laws

Patients with early breast cancer (EBC) could benefit from a targeted treatment that can block or interfere with cancer cell growth.

UK pushes ahead with biggest clinical trial overhaul in 20 years

27-Mar-2023 By Ben Hargreaves

Amid uncertainty over the future of clinical trials in the UK, the MHRA announces that it will streamline the process of running trials to make the country a more ‘attractive destination’.

iOnctura's roginolisob has potential for patients with solid and hematological tumors

21-Mar-2023 By Liza Laws

Non-clinical research has been published about roginolisob, iOnctura’s non-ATP competitive alloseteric modulator of PI3Kδ, for the potential treatment of patients with solid and hematological tumors.

LEO Pharma and ICON plc collaborate to improve outcomes for dermatology patients

14-Mar-2023 By Liza Laws

A strategic partnership between LEO Pharma and ICON plc, a clinical development company, was announced on March 10.

Frontotemporal dementia study expanded by Centogene

06-Mar-2023 By Liza Laws

Mutation in the progranulin (GRN) gene is just one of several hereditary factors that can cause frontotemporal dementia, a rare and rapidly progressive neurodegenerative disease.

Metrion leases facility, adds high-throughput capacity to support ion channel services

08-Dec-2022 By Nick Taylor

Metrion Biosciences has leased a new facility and added high-throughput screening (HTS) capacity to support its ion channel drug discovery projects.

Altasciences expands Missouri bioanalytical site to support preclinical and clinical studies

01-Nov-2022 By Nick Taylor

Altasciences is expanding its facility in Columbia, Missouri to provide bioanalytical services in support of preclinical and clinical studies conducted in the US.

Anji Pharma and Population Health partner to progress lead candidates

31-Oct-2022 By Ben Hargreaves

The biopharma company and investment firm will cooperate to progress late-stage clinical assets in diabetes and chronic idiopathic constipation.

Industry body points to ‘clear and serious threat’ to clinical research in UK

26-Oct-2022 By Ben Hargreaves

The ABPI releases a report that shows the number of clinical trials taking place in the UK fell by a large amount between the years 2017 and 2021.

TransCelerate CEO: Speeding drug development a ‘win-win’ for all concerned

28-Sep-2022

TransCelerate BioPharma continues to work towards “bringing new medicines to patients faster”. We caught up with the organization’s CEO to hear about its main achievements over the past decade and learn about what comes next.

Use of RWE, AI elevating drug development: Sidley

12-Sep-2022 By Jenni Spinner

A fleet of legal professionals offers advice and perspective on important considerations when harnessing artificial intelligence and real-world evidence.

Real-world evidence helps accelerate research: Wolters Kluwer Health

12-Sep-2022 By Jenni Spinner

Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines.

Clarify, Datavant team up to securely connect first-party and real-world data

07-Sep-2022 By Nick Taylor

The companies will work together to help clients connect information sources, giving stakeholders a better overview of the clinical patient experience.

Sanofi strikes $20m AI drug discovery deal with Atomwise

07-Sep-2022 By Nick Taylor

The pharma company’s collaboration with the drug discovery specialist involves using artificial intelligence to discover and develop up to five drug targets.

Charles River opens research facilities in California and Washington

30-Aug-2022 By Jane Byrne

Organization extends turnkey research facility network to San Diego, San Francisco, Thousand Oaks, and Seattle.

Celanese lands Gates Foundation grant for refillable contraceptive research

29-Aug-2022 By Jenni Spinner

The company has landed funding from the Bill and Melinda Gates Foundation for research and development on a prototype of a refillable contraceptive solution.

BMS expands precision oncology portfolio with Turning Point acquisition

18-Aug-2022 By Jenni Spinner

The pharmaceutical company has completed acquisition of Turning Point Therapeutics, a company specializing in precision medicine solutions for cancer patients.

Merck engages Saama Technologies to build ‘clinical data layer’

18-Aug-2022 By Jenni Spinner

The pharma firm will leverage the ClinTech leader's Life Science Analytics Cloud to bolster development capabilities and accelerate pipeline progress.

Auransa, Polaris harness AI, quantum computing to discover cancer drugs

16-Aug-2022 By Jenni Spinner

The AI and QC specialists have joined to use AI and QC in order to discover biological pathways relevant to the treatment of triple-negative breast cancer.

Merck partners with Cerevance on Alzheimer’s research initiative

11-Aug-2022 By Jenni Spinner

The pharmaceutical company has inked a strategic collaboration with the drug discovery firm, centering on uncovering novel targets in Alzheimer’s disease.

J&J, Evotec partner on ectodomain shedding drug discovery project

11-Aug-2022 By Jenni Spinner

Janssen has formed a strategic collaboration with the drug discovery specialist that involves applying TargetAlloMod platforms to protein homeostasis.

MCI OneHealth, MDClone team up to use synthetic data to accelerate research

09-Aug-2022 By Nick Taylor

The two companies are collaborating to generate subject data sets designed to help users find insights that can speed up research and improve patient care.

Medical specialty societies can benefit from regulatory progress: IQVIA

04-Aug-2022 By Jenni Spinner

An expert from the trial tech firm explains how the 21st Century Cures Act and other recent regulatory advancements can elevate clinical data registries.

Boehringer, Seqster ink 3-year health data deal to accelerate research

04-Aug-2022 By Nick Taylor

The pharmaceutical company has forged a partnership with the life-sciences tech firm in an effort to elevate data collection and speed up clinical studies.

Blending human knowhow, artificial intelligence aids drug discovery

02-Aug-2022 By Jenni Spinner

A leader from pharmaceutical firm Astellas discusses how the company has put to use a discovery platform that combines human expertise, AI, and robotics.

Cancer Moonshot meeting brings together survivors, industry leaders

26-Jul-2022 By Jenni Spinner

The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Biden’s call to improve screening and treatment options.

Collaboration sets sights on acceleration of cystic fibrosis research

20-Jul-2022 By Jenni Spinner

Epistemic AI, Cincinnati Children’s Hospital Medical Center, and Boomer Esiason Foundation are working together to advance research into the rare disease.

Lymphoma Research Foundation awards $5.7m to pursue blood cancer treatments

12-Jul-2022 By Jenni Spinner

The organization has given 29 research grants to scientists representing 17 different US institutions pursuing lymphoma treatments and cures in their work.

Precision medicine advancements good news for drug development

12-Jul-2022 By Jenni Spinner

A leader from healthcare commercial intelligence company Definitive Healthcare discusses the rise of precision medicine and the benefits the field can yield.

Sema4, Avera Health partner on precision cancer care initiative

07-Jul-2022 By Jenni Spinner

The health care system and analytics company are joining on the ASAP study, a program that constitutes a five-year commitment to advancing cancer solutions.

Indiana University Health enlists LifeOmic platform for cancer research

06-Jul-2022 By Jenni Spinner

The academic research center has adopted the life science technology company’s cloud-based platform for cancer research, drug discovery, and clinical trials.

AstraZeneca to buy blood cancer focused biotech in deal valued at up to $1.27bn

05-Jul-2022 By Jane Byrne

AstraZeneca is to acquire US-based blood cancer specialist, TeneoTwo, in a deal worth around US$1.27bn.

Lilly enlists Sidekick for breast cancer digital therapeutic

30-Jun-2022 By Nick Taylor

The pharmaceutical firm will work with the health tech company to create a digital therapeutic intended for patients dealing with a breast cancer diagnosis.

Gates Foundation to fund pediatric brain research in low-income areas

28-Jun-2022 By Jenni Spinner

The Bill and Melinda Gates Foundation grant, awarded to data management platform Flywheel, will support pediatric brain development in impoverished areas.

Sanofi pushes to accelerate medical writing, reporting processes

27-Jun-2022 By Nick Taylor

The pharmaceutical company has enlisted the help of the AI and NLP tech specialist to streamline clinical study report generation and submission processes.

The Method rolls out experience for living as a Type 2 diabetes patient for a day

27-Jun-2022 By Nick Taylor

The company has added Type 2 diabetes to the list of conditions it simulates in it’s A Life in a Day program, enabling people to spend a day living as if they have the disease.

Survey: most people believe in need for more cancer research

21-Jun-2022 By Jenni Spinner

A new survey reveals the majority of the general public thinks more cancer research is in order, but many are reluctant to pitch in to the effort financially.

Tech Innovations: June 2022

16-Jun-2022 By Jenni Spinner

This month’s announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.

Innovative Trials partners with MS Society on multiple sclerosis R&D

13-Jun-2022 By Nick Taylor

The patient recruitment solutions company plans to work with the charity to support research and clinical trials through a range of fundraising activities.

dia 2022

Collaboration, innovation to take center stage at DIA 2022

08-Jun-2022 By Jenni Spinner

This year’s DIA Global Annual Meeting (taking place June 19-23 in Chicago) reunites professionals for face-to-face learning and networking opportunities.

dia 2022

DIA offers tracks to deliver focused educational experience

08-Jun-2022 By Jenni Spinner

Offering 13 topic tracks to choose from, the DIA Global Annual Meeting (scheduled June 19-23) lets attendees chose the path that fits their unique interests.

bio international 2022

BIO International 2022 to bring insights, athletes to San Diego

06-Jun-2022 By Jenni Spinner

Coming back to the real world June 13-16, the industry event will offer face-to-face learning, networking opportunities, and fun, star-studded opportunities.

Danish National Genome Center, Lifebit form personalized medicine partnership

01-Jun-2022 By Jenni Spinner

The Lifebit CloudOS will be employed to create a Federate Trusted Research Environment within the center’s supercomputing cluster to handle data management.

How Lithuania aims to become a leading European biotech hub

01-Jun-2022 By Ben Hargreaves

Lithuania’s life sciences industry is growing at one of the fastest rates in Europe. Ahead of BIO, Innovation Agency Lithuania explains what the country’s plans are for future growth in the area and how this is built upon students heading into STEM studies.

Lithuanian CDMO to open facility in Boston

25-May-2022 By Jane Byrne

Northway Biotech, a contract development and manufacturing organization (CDMO) based out of Vilnius, Lithuania, is set to open a facility in Boston, US.